Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Protalix BioTherapeutics, Inc. (PLX)
USD2.32
+0.01 (+0.22%)
US AMEX Healthcare Biotechnology
Address
2 University Plaza 7601
Hackensack, NJ, US
Hackensack, NJ, US
CEO
Dror Bashan
Website
protalix.com
IPO
1998-05-15
CIK 1006281 ISIN US74365A3095
Also trades on
New York Stock Exchange American · PLX (USD)
Tel Aviv Stock Exchange · PLX.TA (ILA)
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.32
+0.01 (+0.22%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
746.7K
Beta
0.01
Float Shares
72.07M
Free Float %
89.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.55% | -5.45% | -16.96% | -33.22% | -10.75% | +6.11% | +30.82% | -14.35% | -35.91% | -75.82% | -99.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
2.32
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-2.79
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-1.2% Q1'26: +233.7% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-329.8% Q1'26: +566.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-33.7% Q1'26: +63.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-10.4% Q1'26: +62.7% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-20.9% Q1'26: +118.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-3.1% ★ Q1'26: +8.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-2.06× Q1'26: 0.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
388.0K
est: 236.1K (+64.4%)
|
11.24M
est: 9.78M (+15.0%)
|
8.39M
est: 11.39M (-26.4%)
|
34.42M
est: 35.28M (-2.4%)
|
4.36M
est: 94.30M (-95.4%)
|
9.20M
est: 8.31M (+10.7%)
|
21.08M
est: 27.76M (-24.1%)
|
34.24M
est: 18.60M (+84.1%)
|
54.69M
est: 47.20M (+15.9%)
|
62.90M
est: 55.31M (+13.7%)
|
38.35M
est: 37.59M (+2.0%)
|
47.64M
est: 45.14M (+5.5%)
|
65.49M
est: 38.05M (+72.1%)
|
53.40M
est: 53.94M (-1.0%)
|
52.74M
est: 62.00M (-14.9%)
|
79.05M
78.42M – 79.66M
+27.5% YoY
|
69.04M
61.98M – 76.10M
-12.7% YoY
|
| EBITDA |
-29.98M
est: -63.18M (+52.5%)
|
-26.83M
est: -22.07M (-21.6%)
|
-32.90M
est: -29.82M (-10.3%)
|
-7.93M
est: 14.94M (-153.1%)
|
-21.18M
est: -6.22M (-240.4%)
|
-23.00M
est: -548.2K (-4,095.5%)
|
-71.80M
est: -1.83M (-3,819.9%)
|
-17.10M
est: -1.23M (-1,293.5%)
|
-8.69M
est: -3.11M (-179.1%)
|
4.45M
est: -3.65M (+221.9%)
|
-18.94M
est: -19.24M (+1.5%)
|
-10.78M
est: -21.55M (+50.0%)
|
12.94M
est: -3.63M (+456.3%)
|
6.52M
est: -5.15M (+226.7%)
|
-4.04M
est: -5.92M (+31.8%)
|
-7.54M
-7.60M – -7.48M
-27.5% YoY
|
-6.59M
-7.26M – -5.92M
+12.7% YoY
|
| EBIT |
-31.97M
est: -66.81M (+52.1%)
|
-29.97M
est: -26.28M (-14.0%)
|
-36.53M
est: -33.21M (-10.0%)
|
-11.58M
est: 9.02M (-228.5%)
|
-23.55M
est: -8.40M (-180.5%)
|
-24.98M
est: -739.8K (-3,277.3%)
|
-73.72M
est: -2.47M (-2,882.7%)
|
-18.77M
est: -1.66M (-1,033.6%)
|
-10.31M
est: -4.20M (-145.3%)
|
3.15M
est: -4.92M (+163.9%)
|
-20.06M
est: -21.51M (+6.7%)
|
-11.87M
est: -23.90M (+50.3%)
|
11.75M
est: -4.56M (+357.5%)
|
5.22M
est: -6.47M (+180.6%)
|
-5.50M
est: -7.43M (+26.0%)
|
-9.48M
-9.55M – -9.40M
-27.5% YoY
|
-8.28M
-9.12M – -7.43M
+12.7% YoY
|
| Net Income |
-31.44M
est: -66.08M (+52.4%)
|
-29.00M
est: -25.20M (-15.1%)
|
-36.53M
est: -33.29M (-9.7%)
|
-11.62M
est: 9.51M (-222.2%)
|
58.04M
est: 405.29M (-85.7%)
|
-29.37M
est: -308.02M (+90.5%)
|
-83.44M
est: -364.76M (+77.1%)
|
-26.46M
est: -235.07M (+88.7%)
|
-18.28M
est: -152.39M (+88.0%)
|
-6.52M
est: -27.15M (+76.0%)
|
-27.58M
est: -28.69M (+3.9%)
|
-14.93M
est: -31.86M (+53.2%)
|
8.31M
est: -15.83M (+152.5%)
|
2.93M
est: 923.4K (+217.5%)
|
-6.60M
est: -6.60M (+0.0%)
|
17.09M
13.05M – 19.96M
+358.8% YoY
|
5.49M
5.13M – 5.87M
-67.9% YoY
|
| SGA |
7.14M
est: 57.2K (+12,388.2%)
|
6.88M
est: 6.73M (+2.1%)
|
6.93M
est: 6.59M (+5.1%)
|
9.76M
est: 16.21M (-39.8%)
|
7.28M
est: 22.85M (-68.1%)
|
9.36M
est: 2.01M (+364.6%)
|
11.53M
est: 6.73M (+71.4%)
|
10.92M
est: 4.51M (+142.2%)
|
9.90M
est: 11.44M (-13.5%)
|
11.15M
est: 13.41M (-16.8%)
|
12.73M
est: 12.01M (+6.0%)
|
11.71M
est: 13.02M (-10.1%)
|
14.96M
est: 9.56M (+56.5%)
|
12.19M
est: 13.55M (-10.0%)
|
11.68M
est: 15.57M (-25.0%)
|
19.86M
19.70M – 20.01M
+27.5% YoY
|
17.34M
15.57M – 19.12M
-12.7% YoY
|
| EPS |
-0.41
est: 1.38 (-129.7%)
|
-0.36
est: -3.73 (+90.3%)
|
-4.30
est: -3.74 (-15.0%)
|
-1.30
est: -5.19 (+75.0%)
|
0.61
est: 5.00 (-87.8%)
|
-0.29
est: -3.80 (+92.4%)
|
-6.50
est: -4.50 (-44.4%)
|
-1.80
est: -2.90 (+37.9%)
|
-1.23
est: -1.88 (+34.6%)
|
-0.22
est: -0.34 (+34.3%)
|
-0.62
est: -0.59 (-5.1%)
|
-0.31
est: -0.39 (+20.5%)
|
0.12
est: -0.20 (+159.5%)
|
0.04
est: 0.02 (+169.3%)
|
-0.08
est: 0.03 (-380.3%)
|
0.22
0.17 – 0.25
+616.7% YoY
|
0.07
0.07 – 0.07
-67.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-12.12M
OE per share TTM
-0.15
Owner's Yield
-8.08%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
19.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
40
Total invested
6.37M
Insider transactions (90d)
0
Beneficial owners (>5%)
28
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 13,293,785 (see Item 4) | 13.29M | 9.99% | — | 13.29M | — | 13.29M | HC, IN | United States of America | 2017-02-14 | ↗ |
| 2 | 9.99% (see Item 4) | 13.29M | 9.99% | — | 13.29M | — | 13.29M | IA, OO | United States of America | 2017-02-14 | ↗ |
| 3 | Martin | 9.41M | 6.00% | — | 9.41M | — | — | HC | States of America | 2019-02-12 | ↗ |
| 4 | Nineteen77 Global Multi-Strategy Alpha Master Limited | 9.41M | 6.00% | — | 9.41M | — | 9.41M | CO, OO | Citizenship or Place of Organization | 2019-02-12 | ↗ |
| 5 | Russell | 9.41M | 6.00% | — | 9.41M | — | — | HC | States of America | 2019-02-12 | ↗ |
| 6 | Global Multi-Strategy Alpha Master Limited | 8.94M | 6.00% | — | 8.94M | — | 8.94M | OO | Islands | 2018-02-12 | ↗ |
| 7 | Highbridge Tactical Credit Master Fund, L.P. | 5.40M | 9.99% | — | 5.40M | — | — | PN | State of Delaware | 2021-02-09 | ↗ |
| 8 | Federated Investors, Inc. | 4.85M | 3.74% | 4.85M | — | 4.85M | — | HC | Citizenship or place of Organization | 2017-07-10 | ↗ |
| 9 | J. Christopher Donahue | 4.85M | 3.74% | — | 4.85M | — | 4.85M | IN | Citizenship or place of Organization | 2017-07-10 | ↗ |
| 10 | Rhodora J. Donahue | 4.85M | 3.74% | — | 4.85M | — | 4.85M | IN | Citizenship or place of Organization | 2017-07-10 | ↗ |
| 11 | Thomas R. Donahue | 4.85M | 3.74% | — | 4.85M | — | 4.85M | IN | Citizenship or place of Organization | 2017-07-10 | ↗ |
| 12 | Voting Shares Irrevocable Trust | 4.85M | 3.74% | 4.85M | — | 4.85M | — | OO | Citizenship or place of Organization | 2017-07-10 | ↗ |
| 13 | Alfred Akirov | 3.33M | 9.99% | — | 3.33M | — | 3.33M | IN | Citizenship or Place of Organization | 2020-03-30 | ↗ |
| 14 | Dexcel Pharma Technologies Ltd. | 3.29M | 9.99% | 3.29M | — | 3.29M | — | CO | Israel | 2020-03-25 | ↗ |
| 15 | Angels Investments in Hi Tech Ltd . | 3.29M | 9.90% | 3.29M | — | 3.29M | — | CO | Israel | 2020-11-24 | ↗ |
| 16 | Alrov Properties & Lodgings Ltd. | 3.20M | 9.99% | — | 3.20M | — | 3.20M | CO | Citizenship or Place of Organization | 2020-03-30 | ↗ |
| 17 | Whitebox Advisors LLC | 2.82M | 5.65% | — | 2.82M | — | 2.82M | IA | Delaware | 2022-06-09 | ↗ |
| 18 | Whitebox General Partner LLC | 2.82M | 5.65% | — | 2.82M | — | 2.82M | OO | Delaware | 2022-06-09 | ↗ |
| 19 | Burrage Capital Management | 2.47M | 7.41% | 2.47M | — | 2.47M | — | — | United States of America | 2021-02-12 | ↗ |
| 20 | Highbridge Capital Management, LLC | 2.41M | 5.03% | — | 2.41M | — | — | IA, OO | State of Delaware | 2022-02-14 | ↗ |
| 21 | O’Connor LLC | 941.2K | 6.00% | 941.2K | — | 941.2K | — | IA | Delaware | 2020-03-09 | ↗ |
| 22 | Citigroup Financial Products Inc. | 921.4K | 2.70% | — | 921.4K | — | 921.4K | CO | New York | 2021-02-08 | ↗ |
| 23 | Citigroup Global Markets Holdings Inc. | 921.4K | 2.70% | — | 921.4K | — | 921.4K | HC | New York | 2021-02-08 | ↗ |
| 24 | Citigroup Global Markets Inc. | 921.4K | 2.70% | — | 921.4K | — | 921.4K | BD | New York | 2021-02-08 | ↗ |
| 25 | Citigroup Inc. | 921.4K | 2.70% | — | 921.4K | — | 921.4K | HC | New York | 2021-02-08 | ↗ |
| 26 | Barington Companies Equity Partners, L.P. | 597.2K | 0.84% | — | 12.54M | — | 12.54M | PN | Cayman Islands | 2017-02-15 | ↗ |
| 27 | Technorov Holdings (1993) Ltd. | 68.6K | 0.21% | — | 68.6K | — | 68.6K | CO | Citizenship or Place of Organization | 2020-03-30 | ↗ |
| 28 | Alrov Holdings Technologies Ltd. | 49.7K | 0.15% | — | 49.7K | — | 49.7K | CO | Citizenship or Place of Organization | 2020-03-30 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
40
-44 vs prev Q
New positions
10
Closed positions
52
Increased
20
Reduced
6
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 3.65M +96.1K (+2.7%) | 6.56M -1.3M (-16.7%) | 4.60% +0.086 pp | 0.00% +0.000 pp | USD1.52 +18.4% | 6 qtrs — |
| 2 | OPALEYE MANAGEMENT INC. | 2.48M -102.4K (-4.0%) | 4.46M -1.3M (-22.1%) | 3.13% -0.155 pp | 0.59% -0.221 pp | USD2.22 -18.9% | 2 qtrs — |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 1.26M -52.1K (-4.0%) | 2.27M -646.2K (-22.1%) | 1.59% -0.079 pp | 0.00% 0.000 pp | USD1.68 +7.1% | 16 qtrs — |
| 4 | NORTHERN TRUST CORP | 865.7K -36.8K (-4.1%) | 1.56M -445.2K (-22.2%) | 1.09% -0.055 pp | 0.00% 0.000 pp | USD1.74 +3.4% | 11 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 830.1K +10.3K (+1.3%) | 1.49M -325.8K (-17.9%) | 1.05% +0.005 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 6 | STATE STREET CORP | 585.3K +86.7K (+17.4%) | 1.05M -53.3K (-4.8%) | 0.74% +0.104 pp | 0.00% +0.000 pp | USD1.60 +12.5% | 3 qtrs — |
| 7 | STRATOS WEALTH PARTNERS, LTD. | 500.0K +— (+0.0%) | 900.0K -210.0K (-18.9%) | 0.63% -0.005 pp | 0.01% -0.003 pp | USD1.62 +11.1% | 6 qtrs — |
| 8 | VANGUARD GROUP INC | 488.6K +24.1K (+5.2%) | 879.4K -151.6K (-14.7%) | 0.62% +0.026 pp | 0.00% +0.000 pp | USD1.50 +20.0% | 3 qtrs — |
| 9 | JANE STREET GROUP, LLC | 289.9K +289.9K (+100.0%) | 521.9K +521.9K (+100.0%) | 0.37% +0.366 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 10 | GOLDMAN SACHS GROUP INC | 262.8K +112.0K (+74.2%) | 473.1K +138.2K (+41.3%) | 0.33% +0.140 pp | 0.00% +0.000 pp | USD2.09 -13.9% | 11 qtrs — |
| 11 | UBS GROUP AG | 262.5K +72.2K (+38.0%) | 472.5K +50.1K (+11.9%) | 0.33% +0.089 pp | 0.00% +0.000 pp | USD1.90 -5.3% | 14 qtrs — |
| 12 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 232.1K -168.3K (-42.0%) | 417.8K -471.1K (-53.0%) | 0.29% -0.216 pp | 0.00% -0.002 pp | USD2.53 -28.9% | 4 qtrs — |
| 13 | MAIN STREET FINANCIAL SOLUTIONS, LLC | 214.1K +85.0K (+65.8%) | 385.4K +98.8K (+34.5%) | 0.27% +0.106 pp | 0.03% +0.011 pp | USD2.05 -12.2% | 2 qtrs — |
| 14 | BANK OF NEW YORK MELLON CORP | 210.9K +72.3K (+52.2%) | 379.6K +72.0K (+23.4%) | 0.27% +0.090 pp | 0.00% +0.000 pp | USD1.60 +12.5% | 3 qtrs — |
| 15 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189.1K +— (+0.0%) | 340.4K -79.4K (-18.9%) | 0.24% -0.002 pp | 0.01% -0.002 pp | USD1.41 +27.7% | 24 qtrs — |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 175.1K +— (+0.0%) | 315.1K -73.5K (-18.9%) | 0.22% -0.002 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 17 | COMMONWEALTH EQUITY SERVICES, LLC | 171.8K +— (+0.0%) | 309.2K -71.8K (-18.8%) | 0.22% -0.002 pp | 0.00% 0.000 pp | USD1.42 +26.8% | 8 qtrs — |
| 18 | EVERGREEN CAPITAL MANAGEMENT LLC | 171.3K +— (+0.0%) | 308.4K -72.0K (-18.9%) | 0.22% -0.002 pp | 0.01% -0.002 pp | USD1.48 +21.6% | 3 qtrs — |
| 19 | ROUND ROCK ADVISORS, LLC | 155.1K +155.1K (+100.0%) | 279.2K +279.2K (+100.0%) | 0.20% +0.196 pp | 0.04% +0.042 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 20 | DIAMETRIC CAPITAL, LP | 138.9K -41.1K (-22.8%) | 250.1K -149.5K (-37.4%) | 0.18% -0.054 pp | 0.07% -0.081 pp | USD1.63 +10.4% | 3 qtrs — |
| 21 | MORGAN STANLEY | 132.0K +61.0K (+85.8%) | 237.6K +79.9K (+50.6%) | 0.17% +0.076 pp | 0.00% +0.000 pp | USD1.67 +7.8% | 19 qtrs — |
| 22 | BARCLAYS PLC | 112.8K +78.5K (+228.8%) | 203.1K +168.1K (+480.2%) | 0.14% +0.099 pp | 0.00% +0.000 pp | USD1.72 +4.7% | 16 qtrs — |
| 23 | NUVEEN, LLC | 90.2K +— (+0.0%) | 162.3K -37.9K (-18.9%) | 0.11% -0.001 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 24 | WELLS FARGO & COMPANY/MN | 79.0K +36.2K (+84.5%) | 142.2K +47.1K (+49.6%) | 0.10% +0.045 pp | 0.00% +0.000 pp | USD1.69 +6.5% | 3 qtrs — |
| 25 | LAZARD ASSET MANAGEMENT LLC | 71.4K +71.4K (+100.0%) | 128.5K +128.5K (+100.0%) | 0.09% +0.090 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 26 | HRT FINANCIAL LP | 64.6K +64.6K (+100.0%) | 116.0K +116.0K (+100.0%) | 0.08% +0.082 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 27 | ORIN GREEN FINANCIAL, LLC | 61.4K +233.0 (+0.4%) | 110.6K -25.3K (-18.6%) | 0.08% 0.000 pp | 0.04% -0.010 pp | USD1.84 -2.2% | 11 qtrs — |
| 28 | INVESCO LTD. | 50.6K +5.6K (+12.4%) | 91.0K -8.9K (-8.9%) | 0.06% +0.007 pp | 0.00% +0.000 pp | USD1.52 +18.4% | 3 qtrs — |
| 29 | BANK OF AMERICA CORP /DE/ | 46.4K +26.2K (+130.4%) | 83.4K +38.8K (+86.8%) | 0.06% +0.033 pp | 0.00% +0.000 pp | USD1.66 +8.4% | 23 qtrs — |
| 30 | RHUMBLINE ADVISERS | 44.4K -20.8K (-31.9%) | 79.9K -64.9K (-44.8%) | 0.06% -0.027 pp | 0.00% 0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 31 | TWO SIGMA SECURITIES, LLC | 39.8K +39.8K (+100.0%) | 71.7K +71.7K (+100.0%) | 0.05% +0.050 pp | 0.01% +0.010 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 32 | PRICE T ROWE ASSOCIATES INC /MD/ | 35.3K +— (+0.0%) | 64.0K -15.0K (-19.0%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 33 | XTX TOPCO LTD | 34.3K -51.5K (-60.0%) | 61.7K -128.8K (-67.6%) | 0.04% -0.066 pp | 0.00% -0.008 pp | USD2.11 -14.7% | 6 qtrs — |
| 34 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 33.2K +993.0 (+3.1%) | 59.8K -11.8K (-16.4%) | 0.04% +0.001 pp | 0.00% +0.000 pp | USD1.49 +20.8% | 3 qtrs — |
| 35 | INTECH INVESTMENT MANAGEMENT LLC | 31.1K -115.0 (-0.4%) | 56.0K -13.3K (-19.2%) | 0.04% -0.001 pp | 0.00% 0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 36 | NEW YORK STATE COMMON RETIREMENT FUND | 31.1K -10.2K (-24.7%) | 56.0K -35.7K (-38.9%) | 0.04% -0.013 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 37 | JPMORGAN CHASE & CO | 30.9K +883.0 (+2.9%) | 55.6K -11.0K (-16.5%) | 0.04% +0.001 pp | 0.00% +0.000 pp | USD1.51 +19.2% | 11 qtrs — |
| 38 | DIMENSIONAL FUND ADVISORS LP | 28.7K +11.7K (+68.8%) | 51.5K +13.9K (+37.1%) | 0.04% +0.015 pp | 0.00% +0.000 pp | USD1.61 +11.8% | 3 qtrs — |
| 39 | CITADEL ADVISORS LLC | 27.6K +11.8K (+74.7%) | 49.7K +14.6K (+41.6%) | 0.03% +0.015 pp | 0.00% +0.000 pp | USD2.11 -14.7% | 13 qtrs — |
| 40 | APTUS CAPITAL ADVISORS, LLC | 26.6K +883.0 (+3.4%) | 47.9K -9.2K (-16.1%) | 0.03% +0.001 pp | 0.00% 0.000 pp | USD1.91 -5.8% | 16 qtrs — |
| 41 | CAPITAL PERFORMANCE ADVISORS LLP | 26.0K +— (+0.0%) | 46.8K -10.9K (-18.9%) | 0.03% 0.000 pp | 0.00% -0.006 pp | USD1.09 +65.1% | 15 qtrs — |
| 42 | SMARTLEAF ASSET MANAGEMENT LLC | 26.0K +26.0K (+100.0%) | 45.2K +45.2K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.002 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 43 | PRELUDE CAPITAL MANAGEMENT, LLC | 22.2K -27.5K (-55.3%) | 40.0K -70.5K (-63.8%) | 0.03% -0.035 pp | 0.00% -0.006 pp | USD1.48 +21.6% | 3 qtrs — |
| 44 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 21.8K +21.8K (+100.0%) | 39.0K +39.0K (+100.0%) | 0.03% +0.028 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 45 | LIDO ADVISORS, LLC | 15.6K +— (+0.0%) | 34.5K +— (+0.0%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD2.09 -13.9% | 12 qtrs — |
| 46 | MARSHALL WACE, LLP | 19.1K +19.1K (+100.0%) | 34.3K +34.3K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 47 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 18.6K +— (+0.0%) | 33.4K -7.8K (-18.9%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 48 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 18.5K -5.6K (-23.1%) | 33.3K -20.1K (-37.6%) | 0.02% -0.007 pp | 0.00% +0.000 pp | USD2.22 -18.9% | 2 qtrs — |
| 49 | SG AMERICAS SECURITIES, LLC | 17.2K +17.2K (+100.0%) | 31.0K +31.0K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 50 | BNP PARIBAS ARBITRAGE, SNC | 17.0K +1.8K (+11.9%) | 30.6K -3.1K (-9.3%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD1.90 -5.3% | 5 qtrs — |
| 51 | R SQUARED LTD | 14.6K +14.6K (+100.0%) | 26.3K +26.3K (+100.0%) | 0.02% +0.019 pp | 0.01% +0.012 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 52 | PROSHARE ADVISORS LLC | 13.1K +1.2K (+10.2%) | 23.6K -2.8K (-10.7%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD1.51 +19.2% | 3 qtrs — |
| 53 | TWO SIGMA ADVISERS, LP | 12.9K +2.6K (+25.2%) | 23.2K +354.0 (+1.5%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD2.14 -15.9% | 4 qtrs — |
| 54 | ALTSHULER SHAHAM LTD | 12.1K +— (+0.0%) | 21.9K -5.1K (-18.9%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD1.37 +31.4% | 13 qtrs — |
| 55 | CASCADE FINANCIAL PARTNERS, LLC | 12.0K -5.0K (-29.4%) | 21.6K -16.1K (-42.8%) | 0.02% -0.007 pp | 0.00% -0.002 pp | USD1.48 +21.6% | 3 qtrs — |
| 56 | ALLIANCEBERNSTEIN L.P. | 11.7K +— (+0.0%) | 21.1K -4.9K (-18.9%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 57 | EQUITABLE HOLDINGS, INC. | 11.2K +11.2K (+100.0%) | 20.1K +20.1K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 58 | LPL FINANCIAL LLC | 10.3K +— (+0.0%) | 18.5K -4.3K (-18.9%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.22 -18.9% | 2 qtrs — |
| 59 | HARBOUR INVESTMENT MANAGEMENT LLC | 10.1K +— (+0.0%) | 18.2K -4.2K (-18.9%) | 0.01% 0.000 pp | 0.01% 0.000 pp | USD2.00 -10.0% | 11 qtrs — |
| 60 | KESTRA ADVISORY SERVICES, LLC | 10.0K -1.0K (-9.1%) | 18.0K -6.4K (-26.3%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.22 -18.9% | 11 qtrs — |
| 61 | RUSSELL INVESTMENTS GROUP, LTD. | 7.3K -198.0 (-2.7%) | 13.1K -3.5K (-21.1%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.22 -18.9% | 2 qtrs — |
| 62 | LEGAL & GENERAL GROUP PLC | 7.2K -556.0 (-7.2%) | 13.0K -4.3K (-24.7%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 63 | AMERITAS INVESTMENT PARTNERS, INC. | 7.1K +— (+0.0%) | 12.8K -3.0K (-18.9%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 64 | TOWER RESEARCH CAPITAL LLC (TRC) | 6.2K +720.0 (+13.1%) | 11.2K -1.0K (-8.3%) | 0.01% +0.001 pp | 0.00% 0.000 pp | USD2.16 -16.7% | 3 qtrs — |
| 65 | TD WATERHOUSE CANADA INC. | 6.0K +— (+0.0%) | 10.7K -3.3K (-23.5%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD0.83 +116.9% | 17 qtrs — |
| 66 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 4.4K +90.0 (+2.1%) | 8.0K -1.7K (-17.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.49 +20.8% | 3 qtrs — |
| 67 | ROYAL BANK OF CANADA | 3.4K +2.3K (+217.2%) | 6.0K +4.0K (+200.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD1.93 -6.7% | 2 qtrs — |
| 68 | FMR LLC | 2.3K +1.9K (+428.5%) | 4.2K +3.2K (+328.7%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD1.88 -4.3% | 2 qtrs — |
| 69 | AMALGAMATED BANK | 2.3K -112.0 (-4.7%) | 4.0K -1.0K (-20.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.48 +21.6% | 3 qtrs — |
| 70 | CITIGROUP INC | 1.6K -5.0K (-75.3%) | 2.9K -11.7K (-80.0%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD1.56 +15.4% | 11 qtrs — |
| 71 | ADVISOR GROUP HOLDINGS, INC. | 1.2K +500.0 (+71.4%) | 2.2K +874.0 (+68.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD1.82 -1.1% | 13 qtrs — |
| 72 | INVESTMENT RESEARCH & ADVISORY GROUP, INC. | 1.0K +— (+0.0%) | 1.8K -420.0 (-18.9%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD2.13 -15.5% | 4 qtrs — |
| 73 | DEUTSCHE BANK AG\ | 846.00 -64.8K (-98.7%) | 1.5K -144.1K (-99.0%) | 0.00% -0.082 pp | 0.00% +0.000 pp | USD2.22 -18.9% | 2 qtrs — |
| 74 | STERLING CAPITAL MANAGEMENT LLC | 453.00 +284.0 (+168.0%) | 815.00 +440.0 (+117.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.68 +7.1% | 3 qtrs — |
| 75 | GAMMA INVESTING LLC | 355.00 +355.0 (+100.0%) | 639.00 +639.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.80 +0.0% | 1 qtrs NEW |
| 76 | ACTIVEST WEALTH MANAGEMENT | 300.00 +— (+0.0%) | 540.00 -126.0 (-18.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.17 +53.8% | 7 qtrs — |
| 77 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 250.00 +— (+0.0%) | 450.00 -105.0 (-18.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.61 -31.0% | 25 qtrs — |
| 78 | Y.D. MORE INVESTMENTS LTD | 220.00 +— (+0.0%) | 383.00 -105.0 (-21.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.17 +53.8% | 7 qtrs — |
| 79 | SRS CAPITAL ADVISORS, INC. | 39.00 -257.0 (-86.8%) | 71.00 -587.0 (-89.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.21 -18.6% | 2 qtrs — |
| 80 | PNC FINANCIAL SERVICES GROUP, INC. | 20.00 -15.0 (-42.9%) | 36.00 -42.0 (-53.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.20 -18.2% | 2 qtrs — |
| 81 | SBI SECURITIES CO., LTD. | 1.00 -200.0 (-99.5%) | 2.00 -444.0 (-99.6%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.00 +80.0% | 4 qtrs — |
| 82 | STATE OF WYOMING | — -39.0K (-100.0%) | — -86.6K (-100.0%) | 0.00% -0.050 pp | 0.00% -0.010 pp | USD— | 2 qtrs SOLD |
| 83 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | — -25.0 (-100.0%) | — -56.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 84 | VIRTU FINANCIAL LLC | — -16.5K (-100.0%) | — -37.0K (-100.0%) | 0.00% -0.021 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 85 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | — -23.6K (-100.0%) | — -52.4K (-100.0%) | 0.00% -0.030 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 86 | SIMPLEX TRADING, LLC | — -2.9K (-100.0%) | — -6.0K (-100.0%) | 0.00% -0.004 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 87 | TRUVESTMENTS CAPITAL LLC | — -2.5K (-100.0%) | — -5.5K (-100.0%) | 0.00% -0.003 pp | 0.00% -0.001 pp | USD— | 12 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 39 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Schwab International Small-Cap Equity ETF SCHC | 0.04% | 2.27M | 0.06% |
| 2 | iShares Micro-Cap ETF IWC | 0.04% | 607.1K | 0.60% |
| 3 | WisdomTree U.S. SmallCap Fund EES | 0.02% | 168.3K | 0.38% |
| 4 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.70M | 0.24% |
| 5 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 142.2K | 0.06% |
| 6 | State Street SPDR Portfolio MSCI Global Stock Market ETF SPGM | 0.01% | 149.2K | 0.09% |
| 7 | WisdomTree International Efficient Core Fund NTSI | 0.01% | 40.0K | 0.26% |
| 8 | State Street SPDR Portfolio Europe ETF SPEU | 0.01% | 51.9K | 0.07% |
| 9 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 167.5K | 0.30% |
| 10 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 3.3K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
168.00
Cash buys
—
Cash sales
1.00
Net activity
-168
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | Bashan Dror | Director / Officer | P-Purchase | A | Common Stock | 56,000 | 1.81 | 101.4K | 188,516 | D | ↗ |
| 2025-11-18 | Bar-Shalev Amos | Director | S-Sale | D | Common Stock | 168 | 1.87 | 314.16 | 0 | D | ↗ |
| 2025-09-03 | Schwartz Aharon | Director | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | I | ↗ |
| 2025-09-03 | Naos Yaron | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.64 | 82.0K | 50,000 | D | ↗ |
| 2025-09-03 | Melincoff Gwen A | Director | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | I | ↗ |
| 2025-09-03 | Forster Eliot | Director | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | I | ↗ |
| 2025-09-03 | Elze Christian | Director | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | I | ↗ |
| 2025-09-03 | Boudes Pol F | Director | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | I | ↗ |
| 2025-09-03 | Ben Zvi Shmuel | Director | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | I | ↗ |
| 2025-09-03 | Bashan Dror | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 340,000 | 1.64 | 557.6K | 340,000 | D | ↗ |
| 2025-09-03 | Bar-Shalev Amos | Director | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | I | ↗ |
| 2025-08-24 | Mamlok Gilad | Officer | — | — | Stock Option (Right to Buy) | 597,990 | 1.45 | 867.1K | 0 | D | ↗ |
| 2025-06-26 | Elze Christian | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-10 | Schwartz Aharon | Director | P-Purchase | A | Common Stock | 129,000 | 1.60 | 205.9K | 303,000 | D | ↗ |
| 2024-09-23 | Rubin Eyal | Officer | A-Award | A | Common Stock | 99,010 | 0.00 | — | 669,010 | I | ↗ |
| 2024-09-23 | Naos Yaron | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.10 | 110.0K | 100,000 | D | ↗ |
| 2024-04-01 | Bashan Dror | Director / Officer | A-Award | A | Common Stock | 263,960 | 0.00 | — | 2,149,418 | — | ↗ |
| 2023-10-19 | Bashan Dror | Director / Officer | P-Purchase | A | Common Stock | 16,129 | 1.41 | 22.7K | 132,516 | — | ↗ |
| 2023-09-29 | Schwartz Aharon | Director | A-Award | A | Stock Option (Right to Buy) | 61,676 | 1.66 | 102.4K | 61,676 | — | ↗ |
| 2023-09-29 | Melincoff Gwen A | Director | A-Award | A | Stock Options (Right to Buy) | 61,676 | 1.66 | 102.4K | 61,676 | — | ↗ |
| 2023-09-29 | Boudes Pol F | Director | A-Award | A | Stock Options (Right to Buy) | 61,676 | 1.66 | 102.4K | 61,676 | — | ↗ |
| 2023-09-29 | Ben Zvi Shmuel | Director | A-Award | A | Stock Option (Right to Buy) | 61,676 | 1.66 | 102.4K | 61,676 | — | ↗ |
| 2023-09-29 | Bar-Shalev Amos | Director | A-Award | A | Stock Options (Right to Buy) | 61,676 | 1.66 | 102.4K | 61,676 | — | ↗ |
| 2023-09-14 | Forster Eliot | Director | A-Award | A | Stock Options (Right to Buy) | 85,715 | 1.75 | 150.0K | 85,715 | — | ↗ |
| 2023-08-15 | Rubin Eyal | Officer | A-Award | A | Common Stock | 201,903 | 0.00 | — | 570,000 | — | ↗ |
| 2023-08-15 | Naos Yaron | Officer | A-Award | A | Common Stock | 187,344 | 0.00 | — | 200,817 | — | ↗ |
| 2023-08-15 | Hayon Yael | Officer | A-Award | A | Stock Options (Right to Buy) | 35,115 | 1.99 | 69.9K | 35,115 | — | ↗ |
| 2023-08-15 | Bashan Dror | Director / Officer | A-Award | A | Common Stock | 800,000 | 0.00 | — | 1,885,458 | — | ↗ |
| 2023-01-03 | Schwartz Aharon | Director | P-Purchase | A | Common Stock | 110,000 | 1.42 | 155.8K | 174,000 | — | ↗ |
| 2022-09-07 | Schwartz Aharon | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-09-07 | Rubin Eyal | Officer | A-Award | A | Stock Options (Right to Buy) | 350,000 | 1.03 | 360.5K | 350,000 | — | ↗ |
| 2022-09-07 | Naos Yaron | Officer | A-Award | A | Stock Options (Right to Buy) | 340,000 | 0.00 | — | 340,000 | — | ↗ |
| 2022-09-07 | Melincoff Gwen A | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 1.03 | 51.5K | 50,000 | — | ↗ |
| 2022-09-07 | Hayon Yael | Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2022-09-07 | Bronfeld Zeev | Director | A-Award | A | Stock Options (Right to Buy) | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-09-07 | Boudes Pol F | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-09-07 | Ben Zvi Shmuel | Director | A-Award | A | Stock Options (Right to Buy) | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-09-07 | Bashan Dror | Officer | A-Award | A | Stock Options (Right to Buy) | 750,000 | 0.00 | — | 750,000 | — | ↗ |
| 2022-09-07 | Bar-Shalev Amos | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-06-30 | Ben Zvi Shmuel | Director | A-Award | A | Stock Options (Right to Buy) | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2022-04-11 | Bashan Dror | Officer | P-Purchase | A | Common Stock | 68,000 | 1.50 | 102.0K | 68,000 | — | ↗ |
| 2022-02-25 | Rubin Eyal | Officer | A-Award | A | Common Stock | 121,951 | 0.00 | — | 368,097 | — | ↗ |
| 2022-02-25 | Bashan Dror | Director / Officer | A-Award | A | Common Stock | 637,531 | 0.00 | — | 1,085,458 | — | ↗ |
| 2021-06-03 | Dexcel Pharma Technologies Ltd. | 10% Owner | S-Sale | D | Common Stock | 857,506 | 2.25 | 1.93M | 3,637,314 | — | ↗ |
| 2021-06-02 | Dexcel Pharma Technologies Ltd. | 10% Owner | S-Sale | D | Common Stock | 61,211 | 2.56 | 156.6K | 4,494,820 | — | ↗ |
| 2021-02-12 | Dexcel Pharma Technologies Ltd. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 4,556,031 | — | ↗ |
| 2020-08-11 | Rubin Eyal | Officer | A-Award | A | Common Stock | 246,146 | 0.00 | — | 246,146 | — | ↗ |
| 2020-08-11 | Naos Yaron | Officer | A-Award | A | Stock Options (Right to Buy) | 122,656 | 3.59 | 440.3K | 122,656 | — | ↗ |
| 2020-08-11 | Bashan Dror | Director / Officer | A-Award | A | Common Stock | 447,927 | 0.00 | — | 447,927 | — | ↗ |
| 2020-07-05 | Hayon Yael | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-06-07 | Almon Einat Brill | Officer | A-Award | A | Stock Options (Right to Buy) | 196,995 | 3.59 | 707.2K | 196,995 | — | ↗ |
| 2020-04-07 | Schwartz Aharon | Director | P-Purchase | A | Common Stock | 64,000 | 2.43 | 155.3K | 64,000 | — | ↗ |
| 2020-03-11 | Dexcel Pharma Technologies Ltd. | 10% Owner | — | D | Common Stock Purchase Warrants | 2,816,901 | 2.36 | 6.65M | 0 | — | ↗ |
| 2020-02-03 | Bronfeld Zeev | Director | A-Award | A | Stock Options (Right to Buy) | 240,000 | 3.70 | 888.0K | 240,000 | — | ↗ |
| 2020-01-20 | Schwartz Aharon | Director | A-Award | A | Stock Options (Right to Buy) | 40,000 | 3.55 | 142.0K | 40,000 | — | ↗ |
| 2020-01-20 | Melincoff Gwen A | Director | A-Award | A | Stock Options (Right to Buy) | 40,000 | 3.55 | 142.0K | 40,000 | — | ↗ |
| 2020-01-20 | Granot David | Director | A-Award | A | Stock Options (Right to Buy) | 40,000 | 3.55 | 142.0K | 40,000 | — | ↗ |
| 2020-01-20 | Boudes Pol F | Director | A-Award | A | Stock Options (Right to Buy) | 40,000 | 3.55 | 142.0K | 40,000 | — | ↗ |
| 2020-01-20 | Bar-Shalev Amos | Director | A-Award | A | Stock Options (Right to Buy) | 40,000 | 3.55 | 142.0K | 40,000 | — | ↗ |
| 2020-01-01 | Melincoff Gwen A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-01 | Boudes Pol F | Director | — | D | Common Stock | 0 | 0.00 | — | 40 | — | ↗ |
| 2019-09-22 | Rubin Eyal | Officer | A-Award | A | Stock Options (Right to Buy) | 800,000 | 0.20 | 160.0K | 800,000 | — | ↗ |
| 2019-06-30 | Bashan Dror | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 1,600,000 | 0.47 | 750.4K | 1,600,000 | — | ↗ |
| 2018-09-13 | Shaaltiel Yoseph | Officer | A-Award | A | Stock Options (Right to Buy) | 700,000 | 0.56 | 392.0K | 700,000 | — | ↗ |
| 2018-09-13 | Naos Yaron | Officer | A-Award | A | Stock Options (Right to Buy) | 600,000 | 0.56 | 336.0K | 600,000 | — | ↗ |
| 2018-09-13 | Manor Moshe | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 1,300,000 | 0.56 | 728.0K | 1,300,000 | — | ↗ |
| 2018-09-13 | Maimon Yossi | Officer | A-Award | A | Stock Options (Right to Buy) | 700,000 | 0.56 | 392.0K | 700,000 | — | ↗ |
| 2018-09-13 | Almon Einat Brill | Officer | A-Award | A | Stock Options (Right to Buy) | 700,000 | 0.56 | 392.0K | 700,000 | — | ↗ |
| 2018-08-09 | Granot David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-05-29 | Naos Yaron | Officer | — | D | Stock Options (Right to Buy) | 50,000 | 2.65 | 132.5K | 0 | — | ↗ |
| 2017-05-16 | Manor Moshe | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.81 | 40.5K | 50,000 | — | ↗ |
| 2016-12-02 | Camber Capital Management LLC | 10% Owner | S-Sale | D | Common Stock | 2,500,000 | 0.32 | 792.0K | 10,775,000 | — | ↗ |
| 2016-09-15 | Shaaltiel Yoseph | Officer | M-Exempt | A | Common Stock | 122,162 | 0.00 | 122.16 | 585,916 | — | ↗ |
| 2015-12-14 | Maimon Yossi | Officer | P-Purchase | A | Common Stock | 10,000 | 0.78 | 7.8K | 10,000 | — | ↗ |
| 2015-10-19 | Camber Capital Management LLC | 10% Owner | P-Purchase | A | Common Stock | 423 | 1.03 | 435.69 | 13,275,000 | — | ↗ |
| 2015-10-15 | Camber Capital Management LLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 9,274,577 | — | ↗ |
| 2015-03-23 | Shaaltiel Yoseph | Officer | A-Award | A | Stock Options (Right to Buy) | 275,000 | 1.72 | 473.0K | 275,000 | — | ↗ |
| 2015-03-23 | Palash Tzvi | Officer | A-Award | A | Stock Options (Right to Buy) | 125,000 | 1.72 | 215.0K | 125,000 | — | ↗ |
| 2015-03-23 | Maimon Yossi | Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 1.72 | 430.0K | 250,000 | — | ↗ |
| 2015-03-23 | Almon Einat Brill | Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 1.72 | 430.0K | 250,000 | — | ↗ |
| 2014-11-10 | Schwartz Aharon | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-11-01 | Manor Moshe | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-10-02 | Bronfeld Zeev | Director | J-Other | A | Common Stock | 324,372 | 0.00 | — | 2,162,481 | — | ↗ |
| 2014-09-29 | Manor Moshe | Officer | A-Award | A | Stock Options (Right to Buy) | 900,000 | 2.37 | 2.13M | 900,000 | — | ↗ |
| 2014-09-16 | Bronfeld Zeev | Director | J-Other | D | Common Stock | 8,556,371 | 0.00 | — | 1,509,948 | — | ↗ |
| 2014-09-16 | Bio-Cell Ltd | 10% Owner | J-Other | D | Common Stock | 8,556,371 | 0.00 | — | 1,509,948 | — | ↗ |
| 2014-08-13 | Bronfeld Zeev | Director / 10% Owner | S-Sale | D | Common Stock | 4,400,000 | 2.47 | 10.87M | 10,066,319 | — | ↗ |
| 2014-08-13 | Bio-Cell Ltd | 10% Owner | S-Sale | D | Common Stock | 4,400,000 | 2.47 | 10.87M | 10,066,319 | — | ↗ |
| 2014-07-24 | Yanai Shlomo | Director | A-Award | A | Stock Options (Right to Buy) | 150,000 | 3.37 | 505.5K | 150,000 | — | ↗ |
| 2013-08-15 | Akirov Alfred | Director | S-Sale | D | Common Stock | 2,330 | 5.07 | 11.8K | 4,915,383 | — | ↗ |
| 2013-08-14 | Akirov Alfred | Director | S-Sale | D | Common Stock | 100,000 | 5.05 | 505.0K | 4,927,713 | — | ↗ |
| 2013-03-12 | Akirov Alfred | Director | S-Sale | D | Common Stock | 10,000 | 5.70 | 57.0K | 5,027,713 | — | ↗ |
| 2013-03-11 | Akirov Alfred | Director | S-Sale | D | Common Stock | 300 | 5.79 | 1.7K | 5,055,713 | — | ↗ |
| 2013-03-08 | Akirov Alfred | Director | S-Sale | D | Common Stock | 1,898 | 5.95 | 11.3K | 5,056,013 | — | ↗ |
| 2013-03-07 | Akirov Alfred | Director | S-Sale | D | Common Stock | 5,000 | 5.71 | 28.6K | 5,076,346 | — | ↗ |
| 2013-03-06 | Akirov Alfred | Director | S-Sale | D | Common Stock | 2,000 | 5.69 | 11.4K | 5,082,046 | — | ↗ |
| 2012-07-16 | Shaaltiel Yoseph | Director / Officer | A-Award | A | Common Stock | 210,000 | 0.00 | — | 210,000 | — | ↗ |
| 2012-07-16 | Palash Tzvi | Officer | A-Award | A | Common Stock | 102,000 | 0.00 | — | 102,000 | — | ↗ |
| 2012-07-16 | Maimon Yossi | Officer | A-Award | A | Common Stock | 185,000 | 0.00 | — | 185,000 | — | ↗ |
| 2012-07-16 | Lauterbach Sandra Leigh | Officer | A-Award | A | Common Stock | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2012-07-16 | Aviezer David | Director / Officer | A-Award | A | Common Stock | 418,000 | 0.00 | — | 418,000 | — | ↗ |
| 2012-07-16 | Almon Einat Brill | Officer | A-Award | A | Common Stock | 185,000 | 0.00 | — | 185,000 | — | ↗ |
| 2012-05-02 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 300,000 | 7.13 | 2.14M | 463,754 | — | ↗ |
| 2012-05-02 | Maimon Yossi | Officer | M-Exempt | D | Stock Options (Right to Buy) | 75,964 | 0.97 | 73.8K | 0 | — | ↗ |
| 2012-05-02 | Aviezer David | Director / Officer | M-Exempt | A | Common Stock | 123,733 | 0.97 | 120.3K | 450,000 | — | ↗ |
| 2012-05-02 | Almon Einat Brill | Officer | M-Exempt | D | Stock Options (Right to Buy) | 50,000 | 2.65 | 132.5K | 0 | — | ↗ |
| 2010-10-07 | Maimon Yossi | Officer | M-Exempt | D | Stock Options (Right to Buy) | 77,769 | 0.97 | 75.6K | 75,964 | — | ↗ |
| 2010-10-06 | Almon Einat Brill | Officer | M-Exempt | A | Common Stock | 70,000 | 0.97 | 68.0K | 0 | — | ↗ |
| 2010-10-05 | Almon Einat Brill | Officer | S-Sale | D | Common Stock | 20,000 | 9.08 | 181.6K | 0 | — | ↗ |
| 2010-10-04 | Almon Einat Brill | Officer | S-Sale | D | Common Stock | 35,000 | 9.02 | 315.7K | 0 | — | ↗ |
| 2010-09-07 | Maimon Yossi | Officer | M-Exempt | D | Stock Options (Right to Buy) | 70,000 | 0.97 | 68.0K | 153,733 | — | ↗ |
| 2010-09-07 | Almon Einat Brill | Officer | M-Exempt | D | Stock Options (Right to Buy) | 45,260 | 0.97 | 44.0K | 186,848 | — | ↗ |
| 2010-09-03 | Maimon Yossi | Officer | S-Sale | D | Common Stock | 38,500 | 8.00 | 308.0K | 0 | — | ↗ |
| 2010-09-03 | Almon Einat Brill | Officer | S-Sale | D | Common Stock | 27,500 | 8.00 | 220.0K | 0 | — | ↗ |
| 2010-08-29 | Palash Tzvi | Officer | A-Award | A | Stock Options (Right to Buy) | 160,000 | 7.55 | 1.21M | 160,000 | — | ↗ |
| 2010-08-06 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 4,619 | 7.00 | 32.3K | 763,754 | — | ↗ |
| 2010-08-05 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 48,408 | 7.00 | 338.9K | 768,373 | — | ↗ |
| 2010-06-21 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 52,973 | 7.00 | 370.8K | 816,781 | — | ↗ |
| 2010-04-29 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 12,691 | 7.00 | 88.8K | 869,754 | — | ↗ |
| 2010-04-14 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 1,309 | 7.00 | 9.2K | 882,445 | — | ↗ |
| 2010-03-25 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 50,000 | 7.00 | 350.0K | 883,754 | — | ↗ |
| 2010-03-24 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 202,700 | 7.08 | 1.44M | 933,754 | — | ↗ |
| 2010-03-23 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 127,300 | 7.02 | 893.6K | 1,136,454 | — | ↗ |
| 2010-02-25 | Shaaltiel Yoseph | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 145,000 | 6.90 | 1.00M | 145,000 | — | ↗ |
| 2010-02-25 | Maimon Yossi | Officer | A-Award | A | Stock Options (Right to Buy) | 130,000 | 6.90 | 897.0K | 130,000 | — | ↗ |
| 2010-02-25 | Aviezer David | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 6.90 | 1.73M | 250,000 | — | ↗ |
| 2010-02-25 | Almon Einat Brill | Officer | A-Award | A | Stock Options (Right to Buy) | 130,000 | 6.90 | 897.0K | 130,000 | — | ↗ |
| 2010-02-07 | Lauterbach Sandra Leigh | Officer | A-Award | A | Stock Options (Right to Buy) | 160,000 | 6.81 | 1.09M | 160,000 | — | ↗ |
| 2009-12-17 | Lauterbach Sandra Leigh | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-12-02 | Bar-Shalev Amos | Director | P-Purchase | A | Common Stock | 1,000 | 8.68 | 8.7K | 1,000 | — | ↗ |
| 2009-11-12 | Hurvitz Eli | Director | S-Sale | D | Common Stock | 250,000 | 10.76 | 2.69M | 1,514,480 | — | ↗ |
| 2009-10-21 | Aviezer David | Director / Officer | M-Exempt | D | Stock Options (Right to Buy) | 247,490 | 0.12 | 29.7K | 326,267 | — | ↗ |
| 2009-10-20 | Aviezer David | Director / Officer | S-Sale | D | Common Stock | 60,000 | 9.45 | 567.0K | 0 | — | ↗ |
| 2009-10-19 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 43,120 | 9.43 | 406.6K | 1,263,754 | — | ↗ |
| 2009-10-19 | Aviezer David | Director / Officer | S-Sale | D | Common Stock | 150,000 | 9.43 | 1.41M | 0 | — | ↗ |
| 2009-10-19 | Almon Einat Brill | Officer | F-InKind | D | Common Stock | 3,954 | 9.48 | 37.5K | 0 | — | ↗ |
| 2009-10-16 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 25,680 | 9.39 | 241.1K | 1,306,874 | — | ↗ |
| 2009-10-16 | Maimon Yossi | Officer | F-InKind | D | Common Stock | 17,698 | 9.21 | 163.0K | 0 | — | ↗ |
| 2009-10-16 | Almon Einat Brill | Officer | S-Sale | D | Common Stock | 23,680 | 9.39 | 222.4K | 0 | — | ↗ |
| 2009-10-15 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 31,200 | 9.39 | 293.0K | 1,332,554 | — | ↗ |
| 2009-10-15 | Maimon Yossi | Officer | S-Sale | D | Common Stock | 109,700 | 9.50 | 1.04M | 0 | — | ↗ |
| 2009-09-10 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 974 | 7.55 | 7.4K | 7,610,167 | — | ↗ |
| 2009-09-09 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 300 | 7.59 | 2.3K | 7,747,287 | — | ↗ |
| 2009-09-03 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 3,581 | 7.20 | 25.8K | 7,793,241 | — | ↗ |
| 2009-09-01 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 810 | 6.67 | 5.4K | 7,853,241 | — | ↗ |
| 2009-08-28 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 408 | 6.02 | 2.5K | 7,863,241 | — | ↗ |
| 2009-08-27 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 1,050 | 6.05 | 6.4K | 7,891,273 | — | ↗ |
| 2009-08-26 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 134 | 6.12 | 820.08 | 7,944,081 | — | ↗ |
| 2009-08-25 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 29,488 | 6.02 | 177.5K | 8,240,766 | — | ↗ |
| 2009-08-24 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 4,300 | 6.09 | 26.2K | 8,400,724 | — | ↗ |
| 2009-08-21 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 2,100 | 6.10 | 12.8K | 8,516,913 | — | ↗ |
| 2009-08-20 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 2,859 | 6.11 | 17.5K | 8,542,466 | — | ↗ |
| 2009-08-19 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 3,684 | 6.15 | 22.7K | 8,631,913 | — | ↗ |
| 2009-08-18 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 4,638 | 6.07 | 28.2K | 8,764,588 | — | ↗ |
| 2009-08-17 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 7,294 | 6.38 | 46.5K | 8,929,614 | — | ↗ |
| 2009-08-13 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 104 | 5.92 | 615.68 | 9,166,601 | — | ↗ |
| 2009-08-12 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 21,238 | 6.20 | 131.7K | 9,232,851 | — | ↗ |
| 2009-08-11 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 757 | 6.02 | 4.6K | 9,350,559 | — | ↗ |
| 2009-08-10 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 7,215 | 6.20 | 44.7K | 9,403,006 | — | ↗ |
| 2009-08-07 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 2,500 | 6.50 | 16.3K | 9,487,549 | — | ↗ |
| 2009-08-06 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 4,340 | 6.80 | 29.5K | 9,502,549 | — | ↗ |
| 2009-08-05 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 2,700 | 6.86 | 18.5K | 9,520,039 | — | ↗ |
| 2009-08-04 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 3,392 | 7.07 | 24.0K | 9,587,665 | — | ↗ |
| 2009-08-03 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 371 | 7.19 | 2.7K | 9,634,949 | — | ↗ |
| 2009-07-31 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 4,000 | 7.08 | 28.3K | 9,703,667 | — | ↗ |
| 2009-07-24 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 2,000 | 6.24 | 12.5K | 9,771,973 | — | ↗ |
| 2009-07-07 | Maimon Yossi | Officer | F-InKind | D | Common Stock | 12,217 | 4.95 | 60.5K | 0 | — | ↗ |
| 2009-07-07 | Almon Einat Brill | Officer | M-Exempt | D | Stock Options (Right to Buy) | 59,822 | 0.40 | 23.9K | 98,694 | — | ↗ |
| 2009-07-06 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 80,000 | 5.13 | 410.4K | 1,383,754 | — | ↗ |
| 2009-07-06 | Maimon Yossi | Officer | S-Sale | D | Common Stock | 40,000 | 5.13 | 205.2K | 0 | — | ↗ |
| 2009-07-06 | Almon Einat Brill | Officer | S-Sale | D | Common Stock | 44,000 | 5.13 | 225.7K | 0 | — | ↗ |
| 2009-05-18 | Maimon Yossi | Officer | S-Sale | D | Common Stock | 30,000 | 4.00 | 120.0K | 0 | — | ↗ |
| 2009-05-18 | Almon Einat Brill | Officer | F-InKind | D | Common Stock | 4,707 | 3.79 | 17.8K | 40,000 | — | ↗ |
| 2009-05-14 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 10,000 | 3.85 | 38.5K | 1,463,754 | — | ↗ |
| 2009-05-13 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 20,000 | 3.51 | 70.2K | 1,473,754 | — | ↗ |
| 2009-05-12 | Aviezer David | Director / Officer | M-Exempt | D | Stock Options (Right to Buy) | 103,571 | 0.12 | 12.4K | 573,757 | — | ↗ |
| 2009-05-08 | Aviezer David | Director / Officer | S-Sale | D | Common Stock | 5,200 | 3.40 | 17.7K | 0 | — | ↗ |
| 2009-05-06 | Aviezer David | Director / Officer | F-InKind | D | Common Stock | 3,061 | 3.06 | 9.4K | 0 | — | ↗ |
| 2009-05-05 | Aviezer David | Director / Officer | S-Sale | D | Common Stock | 21,600 | 3.07 | 66.3K | 0 | — | ↗ |
| 2009-04-20 | Aviezer David | Director / Officer | M-Exempt | D | Stock Options (Right to Buy) | 52,469 | 0.12 | 6.3K | 755,389 | — | ↗ |
| 2009-04-17 | Aviezer David | Director / Officer | S-Sale | D | Common Stock | 10,000 | 2.56 | 25.6K | 0 | — | ↗ |
| 2009-04-16 | Aviezer David | Director / Officer | S-Sale | D | Common Stock | 6,700 | 2.50 | 16.8K | 0 | — | ↗ |
| 2009-03-13 | Shaaltiel Yoseph | Director / Officer | S-Sale | D | Common Stock | 8,300 | 2.18 | 18.1K | 1,493,754 | — | ↗ |
| 2009-03-13 | Maimon Yossi | Officer | S-Sale | D | Common Stock | 7,500 | 2.23 | 16.7K | 0 | — | ↗ |
| 2009-03-12 | Maimon Yossi | Officer | S-Sale | D | Common Stock | 32,241 | 2.22 | 71.6K | 0 | — | ↗ |
| 2009-03-11 | Maimon Yossi | Officer | S-Sale | D | Common Stock | 8,849 | 2.30 | 20.4K | 0 | — | ↗ |
| 2009-02-25 | Shaaltiel Yoseph | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.65 | 132.5K | 50,000 | — | ↗ |
| 2009-02-25 | Maimon Yossi | Officer | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.65 | 132.5K | 50,000 | — | ↗ |
| 2009-02-25 | Aviezer David | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 100,000 | 2.65 | 265.0K | 100,000 | — | ↗ |
| 2009-02-25 | Almon Einat Brill | Officer | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.65 | 132.5K | 50,000 | — | ↗ |
| 2008-10-10 | FROST PHILLIP MD ET AL | 10% Owner | P-Purchase | A | Common Stock | 2,500 | 1.64 | 4.1K | 9,780,273 | — | ↗ |
| 2008-07-14 | Bar-Shalev Amos | Director | — | I | Common Stock | 0 | 0.00 | — | 6,186,046 | — | ↗ |
| 2008-05-12 | Almon Einat Brill | Officer | S-Sale | A | Common Stock | 41,427 | 2.75 | 113.9K | 0 | — | ↗ |
| 2008-05-11 | Almon Einat Brill | Officer | M-Exempt | D | Stock Options (Right to Buy) | 48,370 | 0.40 | 19.3K | 203,223 | — | ↗ |
| 2008-03-11 | FROST PHILLIP MD ET AL | 10% Owner | P-Purchase | A | Common Stock | 700 | 2.90 | 2.0K | 9,769,773 | — | ↗ |
| 2008-02-25 | Yossi Maimon | Officer | S-Sale | D | Common Stock | 33,300 | 3.18 | 105.8K | 26,700 | — | ↗ |
| 2008-02-22 | Yossi Maimon | Officer | M-Exempt | D | Stock Options (Right to Buy) | 86,176 | 0.97 | 83.8K | 533,796 | — | ↗ |
| 2008-02-07 | Yossi Maimon | Officer | A-Award | A | Stock Options (Right to Buy) | 175,000 | 5.00 | 875.0K | 175,000 | — | ↗ |
| 2008-02-07 | Shaaltiel Yoseph | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 263,728 | 5.00 | 1.32M | 263,728 | — | ↗ |
| 2008-02-07 | Kornberg Roger D. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-23.8K
Shares Outstanding
80.57M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Dror Bashan President and Chief Executive Officer | 401.8K | 279.5K | 190.0K | 169.0K | — | 126.6K | 1.17M | 30.77% | ↗ |
| 2 | 2025 | Eyal Rubin Senior Vice President and Chief Financial Officer | 240.6K | 181.2K | 183.4K | 31.5K | — | 195.8K | 832.5K | 25.81% | ↗ |
| 3 | 2025 | Yaron Naos Senior Vice President, Chief Operating Officer | 232.8K | 90.1K | 77.8K | 79.8K | — | 95.2K | 575.8K | 27.38% | ↗ |
| 4 | 2025 | Gilad Mamlok Senior Vice President and Chief Financial Officer | 133.9K | — | — | 229.7K | — | 41.6K | 405.2K | 56.69% | ↗ |
| 5 | 2024 | Dror Bashan President and Chief Executive Officer | 374.1K | — | 918.3K | 118.8K | — | 116.6K | 1.53M | 67.88% | ↗ |
| 6 | 2024 | Dror Bashan President and Chief Executive Officer | 374.1K | — | 918.3K | 118.8K | — | 116.6K | 1.53M | 67.88% | ↗ |
| 7 | 2024 | Eyal Rubin Senior Vice President and Chief Financial Officer | 287.4K | 130.4K | 288.7K | 55.4K | — | 97.6K | 859.5K | 40.04% | ↗ |
| 8 | 2024 | Eyal Rubin Senior Vice President and Chief Financial Officer | 287.4K | 130.4K | 288.7K | 55.4K | — | 97.6K | 859.5K | 40.04% | ↗ |
| 9 | 2024 | Yaron Naos Senior Vice President, Chief Operating Officer | 215.5K | 95.1K | 166.4K | 77.1K | — | 85.8K | 640.0K | 38.05% | ↗ |
| 10 | 2024 | Yaron Naos Senior Vice President, Operations | 215.5K | 95.1K | 166.4K | 77.1K | — | 85.8K | 640.0K | 38.05% | ↗ |
| 11 | 2023 | Dror Bashan President and Chief Executive Officer | 356.9K | 892.3K | 1.06M | 246.6K | — | 127.6K | 2.68M | 48.72% | ↗ |
| 12 | 2023 | Eyal Rubin Senior Vice President and Chief Financial Officer | 287.7K | 302.5K | 227.3K | 114.9K | — | 96.6K | 1.03M | 33.26% | ↗ |
| 13 | 2023 | Yaron Naos Senior Vice President, Operations | 216.5K | 212.4K | 129.1K | 133.5K | — | 84.9K | 776.4K | 33.82% | ↗ |
| 14 | 2022 | Dror Bashan President and Chief Executive Officer | 360.0K | — | 817.6K | 177.6K | — | 113.2K | 1.47M | 67.78% | ↗ |
| 15 | 2022 | Eyal Rubin Senior Vice President, Chief Financial Officer | 312.5K | 397.7K | 168.7K | 75.9K | — | 103.5K | 1.06M | 23.11% | ↗ |
| 16 | 2022 | Yaron Naos Senior Vice President, Operations | 239.2K | 81.2K | — | 123.3K | — | 89.6K | 533.3K | 23.12% | ↗ |
| 17 | 2021 | Dror Bashan President and Chief | 373.8K | — | 585.2K | 82.4K | — | 116.3K | 1.16M | 57.67% | ↗ |
| 18 | 2021 | Dror Bashan President and Chief Executive Officer | 373.8K | — | 585.2K | 82.4K | — | 116.3K | 1.16M | 57.67% | ↗ |
| 19 | 2021 | Eyal Rubin Senior Vice President, Chief | 325.1K | — | 385.2K | 21.1K | — | 105.5K | 836.8K | 48.55% | ↗ |
| 20 | 2021 | Eyal Rubin Senior Vice President, Chief Financial Officer | 325.1K | — | 385.2K | 21.1K | — | 105.5K | 836.8K | 48.55% | ↗ |
| 21 | 2021 | Einat Brill Almon, Ph.D. Senior Vice President, Chief | 339.9K | — | — | 196.8K | — | 91.0K | 627.8K | 31.35% | ↗ |
| 22 | 2021 | Yaron Naos Senior Vice President, Operations | 246.7K | — | — | 127.3K | — | 131.3K | 505.3K | 25.19% | ↗ |
| 23 | 2020 | Dror Bashan President and Chief | 351.6K | 137.5K | 579.0K | 163.5K | — | 110.3K | 1.34M | 55.33% | ↗ |
| 24 | 2020 | Dror Bashan President and Chief Executive | 351.6K | 137.5K | 579.0K | 163.5K | — | 110.3K | 1.34M | 55.33% | ↗ |
| 25 | 2020 | Eyal Rubin Senior Vice President, Chief | 303.5K | 92.6K | 382.2K | 43.0K | — | 98.7K | 920.1K | 46.21% | ↗ |
| 26 | 2020 | Einat Brill Almon, Ph.D. Senior Vice President, Chief | 293.2K | 200.0K | — | 219.0K | — | 172.5K | 884.7K | 24.75% | ↗ |
| 27 | 2020 | Einat Brill Almon, Ph.D. Senior Vice President, Chief Development Officer | 293.2K | 200.0K | — | 219.0K | — | 172.5K | 884.7K | 24.75% | ↗ |
| 28 | 2019 | Moshe Manor President and Chief Executive Officer | 362.1K | — | — | 39.3K | — | 214.2K | 615.6K | 6.39% | ↗ |
| 29 | 2019 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 290.9K | — | — | 94.0K | — | 83.4K | 468.3K | 20.07% | ↗ |
| 30 | 2019 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 251.5K | — | — | 93.9K | — | 76.8K | 422.2K | 22.25% | ↗ |
| 31 | 2019 | Einat Brill Almon, Ph.D. Senior Vice President, Chief Development Officer | 251.5K | — | — | 93.9K | — | 76.8K | 422.2K | 22.25% | ↗ |
| 32 | 2019 | Dror Bashan President and Chief Executive | 174.7K | — | — | 161.8K | — | 55.1K | 391.6K | 41.32% | ↗ |
| 33 | 2019 | Dror Bashan President and Chief Executive Officer | 174.7K | — | — | 161.8K | — | 55.1K | 391.6K | 41.32% | ↗ |
| 34 | 2019 | Yaron Naos Senior Vice President, Operations | 223.3K | — | — | 79.9K | — | 82.6K | 385.7K | 20.71% | ↗ |
| 35 | 2019 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 209.6K | — | — | 9.1K | — | 87.6K | 306.2K | 2.96% | ↗ |
| 36 | 2019 | Eyal Rubin Senior Vice President, Chief Financial Officer | 81.5K | — | 25.0K | 20.5K | — | 27.2K | 154.2K | 29.49% | ↗ |
| 37 | 2019 | Eyal Rubin Senior Vice President, Chief | 81.5K | — | 25.0K | 20.5K | — | 27.2K | 154.2K | 29.49% | ↗ |
| 38 | 2018 | Moshe Manor President and Chief Executive Officer | 356.6K | 150.0K | — | 106.8K | — | 104.3K | 717.7K | 14.88% | ↗ |
| 39 | 2018 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 282.6K | 140.0K | — | 59.1K | — | 75.8K | 557.6K | 10.60% | ↗ |
| 40 | 2018 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 249.6K | 120.0K | — | 59.1K | — | 75.4K | 504.0K | 11.72% | ↗ |
| 41 | 2018 | Einat Brill Almon, Ph.D. Senior Vice President, Chief Development Officer | 249.6K | 120.0K | — | 59.1K | — | 75.4K | 504.0K | 11.72% | ↗ |
| 42 | 2018 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 288.7K | — | — | 60.6K | — | 84.1K | 433.4K | 13.98% | ↗ |
| 43 | 2018 | Yaron Naos Senior Vice President, Operations | 218.1K | — | — | 40.9K | — | 80.3K | 339.3K | 12.05% | ↗ |
| 44 | 2017 | Moshe Manor President and Chief Executive Officer | 355.3K | 374.0K | — | 103.4K | — | 105.1K | 937.7K | 11.02% | ↗ |
| 45 | 2017 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 282.2K | 363.6K | — | 37.7K | — | 75.4K | 759.0K | 4.97% | ↗ |
| 46 | 2017 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 249.2K | 157.5K | — | 37.7K | — | 74.8K | 519.2K | 7.26% | ↗ |
| 47 | 2017 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 288.3K | 62.2K | — | 41.5K | — | 80.8K | 472.7K | 8.77% | ↗ |
| 48 | 2017 | Tzvi Palash Chief Operating Officer | 220.8K | 117.0K | — | 18.8K | — | 76.1K | 432.8K | 4.35% | ↗ |
| 49 | 2016 | Moshe Manor President and Chief Executive Officer | 333.1K | — | — | 250.3K | — | 98.9K | 682.3K | 36.69% | ↗ |
| 50 | 2016 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 270.2K | — | 18.2K | 103.3K | — | 73.3K | 465.1K | 26.12% | ↗ |
| 51 | 2016 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 264.7K | — | 16.0K | 93.9K | — | 70.2K | 444.8K | 24.72% | ↗ |
| 52 | 2016 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 233.5K | — | 16.0K | 93.9K | — | 66.8K | 410.2K | 26.80% | ↗ |
| 53 | 2016 | Tzvi Palash Chief Operating Officer | 206.8K | — | 8.8K | 46.9K | — | 74.0K | 336.6K | 16.57% | ↗ |
| 54 | 2015 | Moshe Manor President and Chief Executive Officer | 334.7K | — | — | 427.9K | — | 95.8K | 858.4K | 49.84% | ↗ |
| 55 | 2015 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 266.8K | 246.0K | 97.1K | 102.2K | — | 68.4K | 780.5K | 25.54% | ↗ |
| 56 | 2015 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 271.7K | 85.0K | 110.2K | 112.5K | — | 74.1K | 653.5K | 34.08% | ↗ |
| 57 | 2015 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 234.9K | 117.5K | 97.1K | 102.2K | — | 62.4K | 614.1K | 32.46% | ↗ |
| 58 | 2015 | Tzvi Palash Chief Operating Officer | 208.1K | 60.0K | 53.5K | 49.1K | — | 71.2K | 442.0K | 23.23% | ↗ |
| 59 | 2014 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 299.1K | 225.0K | 205.2K | 56.2K | — | 74.5K | 860.0K | 30.40% | ↗ |
| 60 | 2014 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 305.5K | 90.0K | 233.0K | 62.7K | — | 84.7K | 775.9K | 38.10% | ↗ |
| 61 | 2014 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 263.9K | 85.0K | 205.2K | 56.2K | — | 68.5K | 678.8K | 38.51% | ↗ |
| 62 | 2014 | Tzvi Palash Chief Operating Officer | 233.7K | 50.0K | 113.2K | 11.4K | — | 74.5K | 482.8K | 25.80% | ↗ |
| 63 | 2014 | David Aviezer, Ph.D., MBA Former President and Chief Executive Officer | 443.8K | 400.0K | — | — | — | 100.1K | 419.0K | 0.00% | ↗ |
| 64 | 2014 | Moshe Manor President and Chief Executive Officer | 93.7K | — | — | 201.0K | — | 18.4K | 313.0K | 64.20% | ↗ |
| 65 | 2014 | Moshe Manor Current President and Chief Executive Officer | 93.7K | — | — | 201.0K | — | 18.4K | 313.0K | 64.20% | ↗ |
| 66 | 2013 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 527.7K | 50.0K | 870.1K | 213.6K | — | 112.7K | 1.77M | 61.09% | ↗ |
| 67 | 2013 | David Aviezer, Ph.D., MBA Former President and Chief Executive Officer | 527.7K | 50.0K | 870.1K | 213.6K | — | 112.7K | 1.77M | 61.09% | ↗ |
| 68 | 2013 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 302.9K | 120.0K | 429.9K | 140.8K | — | 81.7K | 1.08M | 53.07% | ↗ |
| 69 | 2013 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 292.1K | 110.0K | 378.7K | 126.2K | — | 67.7K | 974.8K | 51.80% | ↗ |
| 70 | 2013 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 261.5K | 100.0K | 378.7K | 126.2K | — | 66.6K | 933.1K | 54.12% | ↗ |
| 71 | 2013 | Tzvi Palash Chief Operating Officer | 231.7K | 20.0K | 208.8K | 72.1K | — | 72.1K | 604.7K | 46.45% | ↗ |
| 72 | 2012 | David Aviezer, Ph.D., MBA Former President and Chief Executive Officer | 494.0K | 675.0K | 861.0K | 1.10M | — | 99.1K | 3.23M | 60.74% | ↗ |
| 73 | 2012 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 494.0K | 675.0K | 861.0K | 1.10M | — | 99.1K | 3.23M | 60.74% | ↗ |
| 74 | 2012 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 283.7K | 225.0K | 409.8K | 608.8K | — | 67.3K | 1.59M | 63.88% | ↗ |
| 75 | 2012 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 244.7K | 215.0K | 361.0K | 547.8K | — | 67.8K | 1.44M | 63.28% | ↗ |
| 76 | 2012 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 268.6K | 157.5K | 361.0K | 544.2K | — | 58.2K | 1.39M | 65.14% | ↗ |
| 77 | 2012 | Tzvi Palash Chief Operating Officer | 216.5K | 35.0K | 199.1K | 152.2K | — | 66.3K | 669.0K | 52.51% | ↗ |
| 78 | 2011 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 531.6K | — | — | 53.6K | — | 114.0K | 699.2K | 7.66% | ↗ |
| 79 | 2011 | Tzvi Palash Chief Operating Officer | 233.5K | — | — | 339.0K | — | 76.5K | 649.0K | 52.24% | ↗ |
| 80 | 2011 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 305.3K | — | — | 27.8K | — | 80.1K | 413.2K | 6.74% | ↗ |
| 81 | 2011 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 286.2K | — | — | 18.3K | — | 69.3K | 373.8K | 4.90% | ↗ |
| 82 | 2011 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 263.4K | — | — | 32.6K | — | 71.1K | 367.0K | 8.87% | ↗ |
| 83 | 2010 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 508.9K | — | — | 145.5K | — | 108.0K | 762.4K | 19.09% | ↗ |
| 84 | 2010 | Sandra L. Lauterbach Vice President, Sales and Commercial Affairs | 186.4K | — | — | 405.6K | — | 62.2K | 654.2K | 61.99% | ↗ |
| 85 | 2010 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 292.1K | 100.0K | — | 70.3K | — | 76.5K | 538.9K | 13.04% | ↗ |
| 86 | 2010 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 251.9K | 20.0K | — | 97.0K | — | 66.6K | 435.5K | 22.27% | ↗ |
| 87 | 2010 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 268.2K | 20.0K | — | 63.2K | — | 68.2K | 419.5K | 15.06% | ↗ |
| 88 | 2010 | Tzvi Palash Chief Operating Officer | 72.0K | — | — | 207.1K | — | 24.1K | 303.1K | 68.31% | ↗ |
| 89 | 2009 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 428.0K | 500.0K | — | 530.0K | — | 62.2K | 1.52M | 34.86% | ↗ |
| 90 | 2009 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 428.0K | — | 500.0K | — | — | 62.2K | 1.52M | 32.89% | ↗ |
| 91 | 2009 | Einat Brill Almon, Ph.D. Vice President, Product Development | 172.2K | — | 160.0K | — | — | 36.9K | 652.5K | 24.52% | ↗ |
| 92 | 2009 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 172.2K | 160.0K | — | 283.4K | — | 36.9K | 652.5K | 43.43% | ↗ |
| 93 | 2009 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 186.5K | 160.0K | — | 253.0K | — | 41.1K | 640.6K | 39.50% | ↗ |
| 94 | 2009 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 186.5K | — | 160.0K | — | — | 41.1K | 640.6K | 24.98% | ↗ |
| 95 | 2009 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 196.3K | 160.0K | — | 225.3K | — | 38.0K | 619.6K | 36.37% | ↗ |
| 96 | 2009 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 196.3K | — | 160.0K | — | — | 38.0K | 619.6K | 25.82% | ↗ |
| 97 | 2009 | Sandra L. Lauterbach Vice President, Sales and Commercial Affairs | — | — | — | — | — | — | — | — | ↗ |
| 98 | 2008 | Iftah Katz Vice President of Operations | 131.5K | — | — | — | — | 35.2K | 1.49M | 0.00% | ↗ |
| 99 | 2008 | David Aviezer, Ph.D., MBA President and CEO | 486.3K | — | — | — | — | 93.2K | 1.14M | 0.00% | ↗ |
| 100 | 2008 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 486.3K | — | — | 565.4K | — | 93.2K | 1.14M | 49.38% | ↗ |
| 101 | 2008 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 486.3K | — | — | — | — | 93.2K | 1.14M | 0.00% | ↗ |
| 102 | 2008 | Yossi Maimon, CPA Chief Financial Officer | 203.1K | 30.7K | — | — | — | 83.8K | 555.8K | 0.00% | ↗ |
| 103 | 2008 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 203.1K | — | 30.7K | — | — | 83.8K | 555.8K | 5.52% | ↗ |
| 104 | 2008 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 203.1K | 30.7K | — | 238.2K | — | 83.8K | 555.8K | 42.86% | ↗ |
| 105 | 2008 | Einat Brill Almon, Ph.D. Vice President, Product Development | 195.6K | — | 28.9K | — | — | 51.2K | 529.6K | 5.46% | ↗ |
| 106 | 2008 | Einat Brill Almon, Ph.D. VP, Product Development | 195.6K | 28.9K | — | — | — | 51.2K | 529.6K | 0.00% | ↗ |
| 107 | 2008 | Einat Brill Almon, Ph.D. Senior Vice President, Product Development | 195.6K | 28.9K | — | 253.9K | — | 51.2K | 529.6K | 47.94% | ↗ |
| 108 | 2008 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 226.7K | — | — | 163.3K | — | 54.7K | 444.7K | 36.73% | ↗ |
| 109 | 2008 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 226.7K | — | — | — | — | 54.7K | 444.7K | 0.00% | ↗ |
| 110 | 2008 | Yoseph Shaaltiel, Ph.D. Executive Vice President | 226.7K | — | — | — | — | 54.7K | 444.7K | 0.00% | ↗ |
| 111 | 2007 | Iftah Katz Vice President of Operations | 114.1K | — | — | — | — | 36.1K | 2.40M | 0.00% | ↗ |
| 112 | 2007 | David Aviezer, Ph.D., MBA President and CEO | 341.1K | 239.2K | — | — | — | 68.0K | 999.6K | 0.00% | ↗ |
| 113 | 2007 | David Aviezer, Ph.D., MBA President and Chief Executive Officer | 341.1K | — | 239.2K | — | — | 68.0K | 999.6K | 23.93% | ↗ |
| 114 | 2007 | Yossi Maimon, CPA Chief Financial Officer | 156.4K | 77.2K | — | — | — | 42.0K | 523.5K | 0.00% | ↗ |
| 115 | 2007 | Yossi Maimon, CPA Vice President, Chief Financial Officer | 156.4K | — | 77.2K | — | — | 42.0K | 523.5K | 14.75% | ↗ |
| 116 | 2007 | Einat Brill Almon, Ph.D. Vice President, Product Development | 153.3K | — | 65.2K | — | — | 42.3K | 355.2K | 18.35% | ↗ |
| 117 | 2007 | Einat Brill Almon, Ph.D. VP, Product Development | 153.3K | 65.2K | — | — | — | 42.3K | 355.2K | 0.00% | ↗ |
| 118 | 2007 | Yoseph Shaaltiel, Ph.D. Executive Vice President | 177.3K | 50.0K | — | — | — | 47.3K | 277.1K | 0.00% | ↗ |
| 119 | 2007 | Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | 117.3K | — | 50.0K | — | — | 47.3K | 277.1K | 18.05% | ↗ |
| 120 | 2006 | David Aviezer, Ph.D., MBA President and CEO | 237.8K | 202.9K | — | — | — | — | 1.18M | 0.00% | ↗ |
| 121 | 2006 | Einat Brill Almon, Ph.D. VP, Product Development | 102.5K | 61.4K | — | — | — | — | 301.8K | 0.00% | ↗ |
| 122 | 2006 | Yoseph Shaaltiel, Ph.D. Executive Vice President | 177.7K | 32.0K | — | — | — | — | 250.8K | 0.00% | ↗ |
| 123 | 2006 | Yossi Maimon, CPA Chief Financial Officer | 27.7K | 32.0K | — | — | — | — | 164.5K | 0.00% | ↗ |
| 124 | 2006 | Iftah Katz Vice President of Operations | — | — | — | — | — | — | — | — | ↗ |
| 125 | 2005 | David Aviezer, Ph.D., MBA President and CEO | 198.9K | 75.0K | — | 272.9K | — | 11.1K | 557.9K | 48.91% | ↗ |
| 126 | 2005 | Einat Brill Almon, Ph.D. VP, Product Development | 85.9K | 3.9K | — | 67.8K | — | 28.1K | 245.8K | 27.60% | ↗ |
| 127 | 2005 | Yoseph Shaaltiel, Ph.D. Executive Vice President | 132.3K | 8.0K | — | 4.1K | — | 38.5K | 182.9K | 2.23% | ↗ |
| 128 | 2005 | Yossi Maimon, CPA Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dror Bashan | President, Chief Executive Officer & Director | 807.9K | male |
| Yaron Naos | SVP & COO | 418.1K | male |
| Gilad Mamlok | Senior VP, CFO Treasurer & Secretary | 309.4K | male |
| Yael Fellous | Vice President of Human Resources | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PLX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
